Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease

Medicine and Dentistry

• Obesity 100%
• Nonalcoholic Fatty Liver 100%
• Thrombospondin 1 100%
• Macrophage 100%
• Non-Alcoholic Fatty Liver Disease 69%
• Liver 40%
• Development 20%
• Combination Therapy 20%
• Diseases 20%
• Insulin 20%
• Cardiovascular Disease 10%
• Lipid Diet 10%
• Therapeutic Procedure 10%
• Patient 10%
• Protein 10%
• Disease Course 10%
• Insulin Resistance 10%
• Tissues 10%
• Adipocyte 10%
• Fatty Liver 10%
• Drive 10%
• Diet 10%
• Liver Injury 10%
• Cell Signaling Pathway 10%
• Disease Exacerbation 10%
• Nephropathy 10%
• Amylin 10%
• Macrophage Activation 10%
• Toll Like Receptor 4 10%
• Chronic Liver Disease 10%
• Hepatitis 10%
• Inflammation 10%
• Liver Cirrhosis 10%
• Liver Fibrosis 10%
• Diet-Induced Obese 10%
• Autocrine Effect 10%
• Steatohepatitis 10%
• Liver Cancer 10%

Biochemistry, Genetics and Molecular Biology

• Macrophage 100%
• Thrombospondin 1 100%
• Development 30%
• Mouse Model 20%
• Mouse 20%
• Insulin 20%
• Insulin Resistance 10%
• Adipocyte 10%
• Drive 10%
• Myeloid 10%
• Knockout Mouse 10%
• Toll-Like Receptor 10%
• Fat 10%
• Amylin 10%
• Macrophage Activation 10%
• Matricellular Protein 10%